The video presented a treatment called Bipolar Androgen Therapy (BAT) for prostate cancer, in which patients are given high doses of testosterone to resensitize the cancer to hormone therapy. Dr. Sam Denme discussed the concept, results from trials, and future research, highlighting the...
Loved this one! True Warrior! “If we continue to do the same things, we will get the same results.” “If BAT can be used to sensitive Xtandi/darolutamide ad infinitum, prostate cancer becomes a treatable condition like diabetes.” – Russ Hollyer Meeting Summary Advanced prostate...
https://www.urotoday.com/video-lectures/pcf-2022/video/2959-bipolar-androgen-therapy-in-the-management-of-prostate-cancer-samuel-denmeade.html Samuel Denmeade, Co-Director of the Johns Hopkins Prostate Cancer Program joins Alicia Morgans in a discussion on Bipolar Androgen Therapy (BAT) for...
Abstract Bipolar androgen therapy (BAT) is a new treatment concept for men whose prostate cancer has become resistant to standard hormone‐blocking therapy. Over the past decade, we have performed a series of clinical studies testing BAT in asymptomatic men with castration‐resistant prostate...
Summary Prostate Cancer Lab #21 discusses the effectiveness of Bipolar Androgen Therapy (BAT) in treating metastatic prostate cancer. The speaker shares their success story with BAT and highlights its potential benefits. Highlights BAT involves alternating between high and low testosterone...
Summary Prostate Cancer Lab #56 focuses on Bipolar Androgen Therapy (BAT) as a potential treatment for castration-resistant prostate cancer. The therapy involves alternating between high-dose testosterone injections and the continuation of testosterone-suppressing drugs. BAT has shown positive...
https://music.amazon.ca/fr-ca/podcasts/3deef1ea-2731-48be-998b-7afc38ee8702/prostate-cancer-clinical-masterclass-series Welcome to The Prostate Cancer Clinical Masterclass Series which is co-chaired by Dr Sumit Subudhi and Dr Gerhardt Attard. This is a twelve-month initiative, consisting of...
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer (2023) Samuel R. Denmeade*,Laura A. Sena, Hao Wang, Emmanuel S. Antonarakis, Mark C. Markowski Abstract Inhibition of androgen receptor (AR) signaling has been the mainstay of treatment...
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications (2022) Rajendra Kumar, Laura A. Sena, Samuel R. Denmeade & Sushant Kachhap Abstract The discovery of the benefits of castration for prostate cancer treatment in 1941 led to androgen...
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question (2022) Irene Caramella ● Alberto Dalla Volta ● Marco Bergamini ● Deborah Cosentini ● Francesca Valcamonico ● Alfredo Berruti Abstract...
ABSTRACT Introduction: Although testosterone therapy (TTh) is the standard practice in otherwise healthy hypogonadal men, this therapy has historically been contraindicated in men with a history of prostate cancer. Recent evidence suggests that there is minimal or no prostate cancer growth in...
Testosterone replacement therapy (TRT) is the primary treatment for male testosterone deficiency. This therapy raises concerns over the risk of prostate cancer (PC) because testosterone has historically been considered the fuel for PC. We discuss the re-evaluation of the relationship between...
Abstract Purpose: To investigate prostate-specific antigen (PSA) and clinical responses to a variety of treatment strategies involving testosterone therapy (TTh) in men with metastatic prostate cancer (mPCa). Materials and Methods: Case records were reviewed for three men with advanced PCa...
ABSTRACT With prostate cancer not observed in eunuchs and total androgen suppression by castration an effective first-line treatment for advanced prostate cancer, the dramatic regression seen in tumour symptoms after castration, lead to the theory that high levels of circulating androgens were...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.